Cabot Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-44,242
Closed -$4.19M 159
2014
Q3
$4.19M Sell
44,242
-6,178
-12% -$558K 1.07% 37
2014
Q2
$4.33M Buy
50,420
+754
+2% +$57.3K 1.09% 37
2014
Q1
$3.47M Buy
49,666
+4,588
+10% +$363K 0.91% 45
2013
Q4
$3.81M Buy
45,078
+19,876
+79% +$1.57M 1% 38
2013
Q3
$1.94M Buy
25,202
+4,794
+23% +$336K 0.58% 83
2013
Q2
$1.19M Buy
+20,408
New +$1.23M 0.41% 91

Other funds holding CELG

Cabot Wealth Management's CELG Position: Q4 2014 in Review

Cabot Wealth Management sold out of Celgene Corp (CELG) in Q4 2014, closing a stake of 44,242 shares — an estimated $4.19M sold.

Cabot Wealth Management first reported a position in CELG in Q2 2013 and held it in 6 quarters. The position peaked at $4.33M in Q2 2014. 1,161 funds tracked by Wall St. Rank hold CELG as of Q4 2014.

  • Cabot Wealth Management reported no remaining Celgene Corp position as of Q4 2014 after selling out during the quarter.
  • Cabot Wealth Management sold 44,242 Celgene Corp shares in Q4 2014, an estimated $4.19M.
  • Cabot Wealth Management first reported a position in Celgene Corp in Q2 2013 and held it in 6 quarters.
  • Cabot Wealth Management's Celgene Corp position peaked at $4.33M in Q2 2014.
  • 1,161 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2014.

Based on Cabot Wealth Management's 13F filing for Q4 2014, filed 13 Feb 2015.